Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18463384 | MEDICAL DEVICE OPERATION METHOD AND DRUG TREATMENT SUPPORT SYSTEM | Non-Final OA | Canon Kabushiki Kaisha |
| 18119456 | FLUORINE-CONTAINING COMPOUND AND CONTRAST AGENT | Non-Final OA | TDK Corporation |
| 18731289 | Oxidative Cyclization Reagents for Chemoselective Tryptophan Bioconjugation | Non-Final OA | The Regents of the University of California |
| 17613351 | APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USING THEREOF | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18284035 | CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF | Non-Final OA | The Regents of the University of Michigan |
| 17783939 | MYELOID CELL-TARGETED NANOPARTICLES AND RELATED COMPOSITIONS AND METHODS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18276311 | LUNG LESION LOCALIZATION MULTI-IMAGING CONTRAST AGENT COMPOSITION FOR RESTRICTIVE LUNG RESECTION | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 17837794 | USE OF LACTIC ACID IN HYPERPOLARIZATION FOR MAGNETIC RESONANCE APPLICATIONS | Non-Final OA | GE PRECISION HEALTHCARE LLC |
| 18032760 | PROINFLAMMATORY PRODRUGS | Non-Final OA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 17796494 | HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES | Non-Final OA | University of Utah Research Foundation |
| 19234864 | STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITION | Final Rejection | Novartis AG |
| 17769960 | ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 17782369 | COMPOSITIONS AND METHODS FOR TUNABLE MAGNETIC NANOPARTICLES | Non-Final OA | The General Hospital Corporation |
| 17910248 | TARGETED NANOBUBBLE THERAPY | Final Rejection | CASE WESTERN RESERVE UNIVERSITY |
| 17865513 | EXOSOME-DELIVERED TARGETING TREATMENT FOR BLOOD VESSELS | Final Rejection | University of South Carolina |
| 18015807 | ASYMMETRIC CHARGED VESICLES AND METHODS OF PREPARING AND USE THEREOF | Non-Final OA | The Research Foundation for the State University of New York |
| 17622580 | TRANSFECTION METHOD | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18555983 | ORAL CARE FLAVOUR FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | Non-Final OA | GIVAUDAN SA |
| 18556014 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | Non-Final OA | GIVAUDAN SA |
| 18259201 | Process for Controlled Manufacturing of Mono-Disperse Microbubbles | Non-Final OA | Solstice Pharmaceuticals B.V. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy